Elia Dirupo

Mr. Elia Dirupo

Meyer Children's Hospital, Florence, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VPVIVIANA PALAZZO
VIVIANA PALAZZO
VRValentina Raglianti
Valentina Raglianti
SLSAMUELA LANDINI
SAMUELA LANDINI
LCLuigi Cirillo
Luigi Cirillo
CECarmela Errichiello
Carmela Errichiello
FBFrancesca Becherucci
Francesca Becherucci
Bartter (BS) and Gitelman (GS) syndrome are autosomal recessive inherited tubulopathies, whose clinical diagnosis can be challenging, due to rarity and phenotypic overlap. Genotype–phenotype correlations have important implications in defining kidney and global outcomes. The aim of our study was to assess the diagnostic rate of whole-exome sequencing (WES) coupled with a bioinformatic analysis of copy number variations in a population of 63 patients with BS and GS from a single institution, and to explore genotype-phenotype correlations. We obtained a diagnostic yield of 86% (54/63 patients), allowing disease reclassification in about 14% of patients. Although some clinical and laboratory features were more commonly reported in patients with BS or GS, a significant overlap does exist, and age at onset, preterm birth, gestational age and nephro-calcinosis are frequently misleading. Finally, chronic kidney disease (CKD) occurs in about 30% of patients with BS or GS, suggesting that the long-term prognosis can be unfavorable. In our cohort the features associated with CKD were lower gestational age at birth and a molecular diagnosis of BS, especially BS type 1. The results of our study demonstrate that WES is useful in dealing with the phenotypic heterogeneity of these disorders, improving differential diagnosis and genotype-phenotype correlation.

15 July 2024 in HemaSphere
Verified
Journal Article
Open access
EAEnrico Attardi
Enrico Attardi
LTLucia Tiberi
Lucia Tiberi
GMGiorgio Mattiuz
Giorgio Mattiuz
DFDaniela Formicola
Daniela Formicola
EDElia Dirupo
Elia Dirupo
Valeria SantiniValeria Santini
Valeria Santini
Relevance of germline (GL) predisposition in myelodysplastic syndromes (MDSs) was stressed in both 2022 WHO and International Consensus classifications, but its incidence is probably underestimated, especially in young adult patients. We selected a cohort of 31 consecutive de novo MDS patients with unusual young age (<60 years). We performed exome sequencing (ES) on DNA extracted from noninvasive sources (peripheral blood and saliva), filtering for a panel of 344 genes specifically tailored for detecting GL variants related to clonal and nonclonal cytopenia. We observed at least one high‐ or low‐confidence GL MDS variant in 7/31 (22.6%) and 9/31 (29.0%) of cases, respectively. Four of 31 patients (12.9%) confirmed having established MDS/AML predisposing disorders. We found heterozygous variants in genes involved in DNA repair/cancer predisposition ( ATM, ATR, FANCM, PARN, BRCA1, BRCA2, CHEK2, MSH2 ) in 9/31 (29.0%) cases and variants affecting ribosome biogenesis ( SBDS ), hematopoietic stem cell ( GATA2 ), and megakaryocyte ( ANKRD26 ) differentiation in single cases. Two cases had variants in RBBP6 , a gene previously described exclusively in familial myeloproliferative neoplasms. Lastly, four cases had variants in genes related to inherited anemias ( CUBN and PIEZO1 genes). Our results showed that “young” MDS patients aged 40–60 years carried reported and unreported GL variants with an unexpectedly high proportion, and these events co‐occurred with somatic mutations recurrent in myeloid neoplasms. We explored the “no man's land” of the young adult MDS cases adopting a practical and scalable diagnostic tool, capable to detect GL variants avoiding invasive methods.

Verified
Journal Article
Open access
PDF file
EMElisa Marziali
Elisa Marziali
ECElia Chiavetta
Elia Chiavetta
SBSara Bargiacchi
Sara Bargiacchi
GMGiorgia Mancano
Giorgia Mancano
RARosangela Artuso
Rosangela Artuso
GBGiacomo Maria Bacci
Giacomo Maria Bacci
Purpose: To describe the long-term, multimodal follow-up and multidisciplinary evaluation of two pediatric patients with CDH3-related retinopathy, discussing the genotypic and phenotypic spectrum of this rare cadherinopathy. Design: Retrospective observational case series. Methods: Two unrelated children with early-onset macular dystrophy and congenital hypotrichosis underwent a comprehensive ophthalmic examination, including spectral-domain optical coherence tomography (SD-OCT), blue-light fundus autofluorescence (BAF), microperimetry, and full-field electroretinography (ffERG), combined with dermatologic assessment and exome sequencing. Follow-up extended over 4 years in Patient 1 and 15 years in Patient 2. Results: Both patients showed sharply demarcated posterior pole chorioretinal atrophy with preservation of the peripheral retina and stable best-corrected visual acuity throughout follow-up. Microperimetry documented localized sensitivity loss with limited progression. SD-OCT revealed persistent ellipsoid zone disruption, retinal pigment epithelium atrophy, and outer retinal tubulations. Dermatologic evaluation confirmed congenital hypotrichosis without nail abnormalities; one patient exhibited mild fifth finger clinodactyly. Genetic testing identified the following two distinct homozygous CDH3 variants: a splice-site mutation (c.160+1G>A) and a frameshift insertion (c.1837dup, p.(Asp613Glyfs*4)). Conclusions:CDH3 retinopathy presents with a characteristic multimodal imaging pattern of localized macular atrophy and slow functional decline associated with congenital hypotrichosis. A comprehensive multidisciplinary approach was essential for the correct diagnosis and a better and more thorough definition of the clinical presentation. Detailed long-term follow-up supports the hypothesis of retinal pigment epithelium dysfunction or maldevelopment rather than widespread retinal degeneration. Recognition of this phenotype is critical for accurate diagnosis, genetic counseling, and future gene-therapy strategies targeting the preserved peripheral retina.

5 March 2025 in Ophthalmic Genetics
Verified
Journal Article
Closed access
GBGiacomo Maria Bacci
Giacomo Maria Bacci
PFPina Fortunato
Pina Fortunato
SCSilvia Cestaro
Silvia Cestaro
LTLucia Tiberi
Lucia Tiberi
EDElia Dirupo
Elia Dirupo
RCRoberto Caputo
Roberto Caputo
Monocentric retrospective case series to describe clinical and molecular peculiarities in a series of pediatric patients in attempting a possible genotype-phenotype correlation. We included 13 pediatric patients from 7 unrelated families (ages 1-18) with biallelic pathogenic and likely pathogenic variants in RDH12 gene. For all our patients segregation analyses were performed in their parents and affected siblings. According to their cooperation, patients underwent a complete ophtalmic examination and imaging with full field standard electroretinography (ffERG), spectral domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF). According to previous studies, we did not observe a conclusive genotype-phenotype correlation in our series, nevertheless we reported 2 new RDH12 likely pathogenic variants. Also, we report clinical data on pediatric patients, with the fundus imaging in the youngest child (2 yo) described in the literature in whom retinal dystrophic changes are already present. This study includes a collection of genotypic and phenotypic data from children with RDH12-associated IRD. These findings will help further characterize RDH12-related retinopathy. Determining the time window of onset of dystrophic changes is critical to research the correct timing for administering possible therapies. More extensive and functional studies are needed in view of the opportunity of gene replacement therapy for RDH12 associated IRD.

6 November 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
DVDebora Vergani
Debora Vergani
LTLucia Tiberi
Lucia Tiberi
AGAnnarita Giliberti
Annarita Giliberti
EDElia Dirupo
Elia Dirupo
LZLaila Zaroili
Laila Zaroili
Angela PeronAngela Peron
Angela Peron
TSPEAR (chr. 21q22.3) encodes a protein involved in tooth development and is predominantly expressed in the enamel knot. Biallelic loss of function variants in TSPEAR cause ectodermal dysplasia, tooth agenesis and sensorineural hearing loss. However, the role of TSPEAR in auditory processes is unclear. This study aimed at better delineating the allelic and clinical spectrum of TSPEAR ‐associated disorders. We identified homozygous and compound heterozygous causative variants in TSPEAR [NM_144991.3] in 11 patients from seven families. Abnormalities in tooth number and shape (conical teeth and tooth agenesis with a variable number of missing teeth) were found in all affected individuals. Maxillary retrusion was present in 6/11. Manifestations in other ectodermal‐derived organs were seen in a minority of patients. None of the individuals had hearing loss. We identified a total of 10 variants, of which seven have not been previously published, and analyzed the effect of missense variants to support their pathogenicity. Our results demonstrate that individuals with biallelic variants in TSPEAR show complete penetrance for dental manifestations, but not for other ectodermal abnormalities. TSPEAR ‐related disorder is more common than previously thought, while hearing loss is not a feature of the disease.